Clark Kenneth A is a director of Summit Therapeutics Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Summit Therapeutics Inc.
4 Jan 24
4
Summit Therapeutics Inc.
5 Jan 23
4
Summit Therapeutics Inc.
5 Jan 22
4
Summit Therapeutics Inc.
12 Oct 21
3
Summit Therapeutics Inc.
12 Oct 21
4
Pulse Biosciences, Inc.
21 May 21
4
Pulse Biosciences, Inc.
19 May 20
4
Pulse Biosciences, Inc.
17 May 19
4
Pulse Biosciences, Inc.
9 Jan 19
4
Pulse Biosciences, Inc.
24 May 18
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
2 Jan 24 | SMMT Summit Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 1.32 | 70,492 | 93.05 k | 105,492 |
2 Jan 24 | SMMT Summit Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 2.64 | 35,000 | 92.40 k | 35,000 |
3 Jan 23 | SMMT Summit Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 1.67 | 44,400 | 74.15 k | 79,400 |
3 Jan 23 | SMMT Summit Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 5 | 35,000 | 175.00 k | 35,000 |